團(tuán)隊(duì)近兩年獲得國(guó)家自然科學(xué)基金1項(xiàng)、科技部專(zhuān)項(xiàng)經(jīng)費(fèi)1項(xiàng)、協(xié)和青年基金1項(xiàng)等縱向基金支持，累計(jì)經(jīng)費(fèi)約200萬(wàn)元。與新疆德源生物工程有限公司建立聯(lián)合實(shí)驗(yàn)室，開(kāi)展“RhD陰性獻(xiàn)漿員抗D免疫研究”，與四川新生命干細(xì)胞建立聯(lián)合實(shí)驗(yàn)室“臍帶血安全有效研究聯(lián)合實(shí)驗(yàn)室”。此外，隨著團(tuán)隊(duì)在行業(yè)影響力不斷擴(kuò)大，重慶市血液中心、山西太原血液中心、云南昆明血液中心及成都中醫(yī)藥大學(xué)、昆明醫(yī)學(xué)院等多家血液中心和醫(yī)院申請(qǐng)到本中心進(jìn)行技術(shù)培訓(xùn)和課題合作。牽頭修訂國(guó)家衛(wèi)生行業(yè)標(biāo)準(zhǔn)《全血及成分血使用指南》，參與《臨床用血技術(shù)規(guī)范》制定。團(tuán)隊(duì)成立近2年來(lái)，團(tuán)隊(duì)師生已發(fā)表SCI論文8篇，核心期刊論文5篇。
The primary research direction of the clinical transfusion medicine center is based on the studies on the risks derived from the practice of blood transfusion. The research studies in our center focuses on the genetic basis of human blood groups with the aim of increasing the efficiency and safety of clinical blood transfusion. We are interested in the identification of complex blood groups, the resolution of antibody problems and the reduction in the rates of immunological transfusion reactions and hemolytic disease of the newborn. We are also interested in the immunological responses involved in organ and HSC transplantation, while providing consultation and corresponding strategies for clinicians. The HLA Lab of our center is a HLA Reference Laboratory affirmed by MOH, as well as Tissue Typing Laboratory of CMDP under the Red Cross Society of China. In the past two years, we have obtained more than 2 million RMB in financial support from National Natural Science Foundation of China, Special Foundation from Ministry of Science and Technology, and Youth Scientist Foundation of PUMC as well as the industry. More than ten papers have been published since the establishment of this center.
PI簡(jiǎn)介：
劉忠
博士，教授，主任技師，博士生導(dǎo)師。畢業(yè)于德國(guó)洪堡大學(xué)醫(yī)學(xué)院?，F(xiàn)任中國(guó)醫(yī)學(xué)科學(xué)院輸血研究所副所長(zhǎng)，北京協(xié)和醫(yī)學(xué)院輸血醫(yī)學(xué)系執(zhí)行主任，《中國(guó)輸血雜志》主編。研究方向：血液安全，臨床輸血，血液保存。先后赴美國(guó)俄亥俄州哥倫布市血液中心、美國(guó)紅十字會(huì)Holland研究中心、日本大阪血液中心學(xué)習(xí)，德國(guó)哥廷根大學(xué)醫(yī)學(xué)院輸血醫(yī)學(xué)系學(xué)習(xí)和做訪問(wèn)學(xué)者的研究，熟悉采供血業(yè)務(wù)及質(zhì)量工作，先后在安徽省血液中心任研究室主任、業(yè)務(wù)副站長(zhǎng)、質(zhì)量副站長(zhǎng)，一直致力于血液安全和保障。承擔(dān)國(guó)家科技支撐項(xiàng)目、國(guó)家自然科學(xué)基金、省國(guó)際科技合作項(xiàng)目等。《中國(guó)輸血雜志》、《國(guó)際血液學(xué)雜志》雜志編委，《臨床輸血與檢驗(yàn)》雜志編委，《Prenatal Diagnosis》論文評(píng)議員等。第41屆國(guó)際低溫醫(yī)學(xué)生物學(xué)大會(huì)秘書(shū)長(zhǎng)。
Tel：86-28-61648562 E-mail: 108349730@qq.com
Dr. Liu Zhong. Professor of CAMS&PUMC, Associate Director of CAMS Institute of Blood Transfusion, Chief Editor of Chinese Journal of Blood Transfusion, Executive Director of Department of Transfusion Medicine in PUMC, Research Instructor. He received his PhD degree at Humboldt-University in Germany. Research directions: Blood safety, clinical transfusion and blood preservation.
He studied in and visited Columbus Blood Center in Ohio, USA, Holland Institute of American Red Cross, Blood Center of Osaka in Japan and Goettingen University in Germany as a guest scientist, gaining more experience in blood collection and supply and quality control work. He also worked as a director of the Research Department, Chief Operating Officer, Chief Quality Officer in Anhui Blood Center, dedicating his lifetime efforts to guarantee blood safety and availability.
He was supported by The National Key Technology R&D Program, National Natural Science Foundation of China, International S&T Cooperation Program of Sichuan. Dr. Liu is on the Editorial Board of Chinese Journal of Blood Transfusion, International Journal of Transfusion and Hematology, Journal of Clinical Transfusion and Laboratory Medicine, and an academic journal reviewer of Prenatal Diagnosis. Dr. Liu was also General Secretary of 41st Congress of International Medical Cryobiology.
